CIK 0001870404 · <br>Emerging growth company
CERO THERAPEUTICS HOLDINGS, INC.
Sign in to watch- Tickers
- CERO CEROW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871088814
- Phone
- 650-407-2376
- Business address
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CERO THERAPEUTICS HOLDINGS, INC., PHOENIX BIOTECH ACQUISITION CORP.
Securities
- CERO Common stock OTC
- CEROW Common stock OTC
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 532,486 shares at $0.10 ($55,538)
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 3,250,000 shares at $0.10 ($325,000)
- 3 Insider Initial Statement of Ownership
Page 11 of 23 · 445 filings